- Home
- CELH vs HALO Comparison
CELH vs HALO Comparison
Compare CELH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- HALO
- Stock Information
- Founded
- CELH 2004
- HALO 1998
- Country
- CELH United States
- HALO United States
- Employees
- CELH N/A
- HALO N/A
- Industry
- CELH Beverages (Production/Distribution)
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CELH Consumer Staples
- HALO Health Care
- Exchange
- CELH Nasdaq
- HALO Nasdaq
- Market Cap
- CELH 7.5B
- HALO 8.0B
- IPO Year
- CELH N/A
- HALO N/A
- Fundamental
- Price
- CELH $33.65
- HALO $63.84
- Analyst Decision
- CELH Buy
- HALO Buy
- Analyst Count
- CELH 17
- HALO 9
- Target Price
- CELH $45.53
- HALO $61.63
- AVG Volume (30 Days)
- CELH 8.9M
- HALO 1.6M
- Earning Date
- CELH 05-06-2025
- HALO 05-06-2025
- Dividend Yield
- CELH N/A
- HALO N/A
- EPS Growth
- CELH N/A
- HALO 63.33
- EPS
- CELH 0.45
- HALO 3.43
- Revenue
- CELH $1,355,630,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- CELH $34.11
- HALO $20.06
- Revenue Next Year
- CELH $17.00
- HALO $23.87
- P/E Ratio
- CELH $74.24
- HALO $18.61
- Revenue Growth
- CELH 2.85
- HALO 22.44
- 52 Week Low
- CELH $21.10
- HALO $37.73
- 52 Week High
- CELH $98.85
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- CELH 64.01
- HALO 62.51
- Support Level
- CELH $33.74
- HALO $63.21
- Resistance Level
- CELH $32.08
- HALO $66.00
- Average True Range (ATR)
- CELH 1.78
- HALO 1.69
- MACD
- CELH 0.51
- HALO -0.03
- Stochastic Oscillator
- CELH 79.66
- HALO 61.57
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.